Cape Verde vs Trinidad and Tobago: New cases tested for RR-/MDR-TB
Cape Verde
4.3%
in 2024
Trinidad and Tobago
31.0%
in 2024
Cape Verde rank
180th
Trinidad and Tobago rank
177th
New cases tested for RR-/MDR-TB over time
- Cape Verde
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 31.0% against 4.3% in Cape Verde, a difference of 26.7%.
That makes Trinidad and Tobago's figure about 7.2 times Cape Verde's.
The two have swapped places 6 times across 14 shared years of data; in 2008 it was Trinidad and Tobago ahead.
Cape Verde ranks 180th and Trinidad and Tobago ranks 177th of 192 countries.
Trinidad and Tobago has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 1.8% | 1.8% | Trinidad and Tobago |
| 2010s | 29.5% | 53.8% | 24.3% | Trinidad and Tobago |
| 2020s | 43.9% | 45.1% | 1.2% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Cape Verde or Trinidad and Tobago?
- Trinidad and Tobago, at 31.0% against 4.3% in Cape Verde as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Cape Verde and Trinidad and Tobago?
- 26.7%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Cape Verde and Trinidad and Tobago?
- 14 years are reported by both, from 2008 to 2024.
- How do Cape Verde and Trinidad and Tobago rank globally for new cases tested for rr-/mdr-tb?
- Cape Verde ranks 180th and Trinidad and Tobago ranks 177th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.